Peter Mæhre Lauritzen

Author information from the last article

Klinikk for radiologi og nukleærmedisin

Oslo universitetssykehus, Ullevål sykehus

Han har bidratt med revisjon og godkjenning av manus.

Peter Mæhre Lauritzen er overlege.

Articles by Peter Mæhre Lauritzen

Should calculation of chemotherapy dosage for bowel cancer be based on body composition?

Ane Sørlie Kværner,
Helene Harnæs,
Dena Helene Alavi,
Linnea Bärebring,
Hege Berg Henriksen,
Marianne Grønlie Guren,
Peter Mæhre Lauritzen,
Heidi Beate Eggesbø,
Gro Wiedswang,
Sigbjørn Smeland,
Rune Blomhoff

19.05.2020: Colorectal cancer is the most prevalent form of cancer among Norwegian men and woman, with 4 428 new cases in 2018 (1). Since the 1940s there has been a doubling of incidence, but also of five-year relative survival, which is now at about 70 % (1). Higher survival is attributed partly to new...